The effect of Ginkgo biloba extract on scopolamine-induced apoptosis in the hippocampus of rats
Apoptosis, known as programmed cell death, plays a crucial role in normal development and tissue homeostasis. Apoptosis is also involved in neurodegenerative diseases such as Alzheimer’s disease. Amnesia refers to the loss of memory and can also be a warning sign of neurodegenerative diseases. The antioxidant properties of Ginkgo biloba extract was known previously. Therefore, the aim of this study was to examine the effects of Ginkgo biloba extract on the rat’s hippocampal apoptotic neurons number after Scopolamine based amnesia. Thirty-six adult male Wistar rats were used. Rats were randomly divided into control, sham, protective and treatment groups. The rats in the sham group received only scopolamine hydrobromide (3 mg/kg) intraperitoneally. The rats in the protective and treatment groups received Ginkgo biloba extract (40, 80 mg/kg) for 7 days intraperitoneally before/after scopolamine injection. Then 48 h after the last injection, the brains of rats were withdrawn and fixed with paraformaldehyde, and then, after histological processing, the slices were stained with the TUNEL kit for apoptotic neurons. Data were compared by the ANOVA Post Hoc Tukey test; P < 0.05 was considered significant. Our results showed that Scopolamine (in the sham group) increased significantly the number of apoptotic neurons in all areas of the hippocampus compared with the control. Whereas, Ginkgo biloba extract reduce the neuronal apoptosis in the hippocampus before and/or after encounter with scopolamine. We concluded that pretreatment and treatment injection of Ginkgo biloba extract can have a protective effect for neurons and it can limit apoptosis in all area of the hippocampus.
KeywordsApoptosis Scopolamine Ginkgo biloba extract Hippocampus Rat
The authors would like to thank the Neuroscience Research Center for behavioral and histological experiments. We are also thankful for financial support of research affaisr of Golestan University of medical sciences. The authors would like to thank the NIAC Pharmaceutical Factory, Gorgan, Iran and Dr. Homan Bayat for donation of Gingko extract to the Neuroscience Research Center.
Conflict of interest
- Azami NS, Jahanshahi M, Babapour V (2010) The role of CA1 α-adrenoceptor on scopolamine induced memory impairment in male rats. Physiol Pharmacol 14:66–77Google Scholar
- Chandrasekaran K, Mehrabian Z, Spinnewyn B, Chinopoulos C, Drieu K, Fiskum G (2003) Neuroprotective effects of bilobalide, a component of ginkgo biloba extract (EGb 761) in global brain ischemia and in excitotoxicity-induced neuronal death. Pharmacopsychiatry 36:89–94Google Scholar
- Coursin D, Cihla H, Sempf J, Oberley T, Oberley L (1996) An immunohistochemical analysis of antioxidant and glutathione S-transferase enzyme levels in normal and neoplastic human lungGoogle Scholar
- Defeudis FV (1998) Ginkgo Biloba (Egb 761). From chemistry to the clinic.) Ullstein MedicalGoogle Scholar
- Oberley T, Oberley L (1997) Antioxidant enzyme levels in cancerGoogle Scholar
- Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates.) Academic Press, San DiegoGoogle Scholar
- Seifhosseini S, Jahanshahi M, Moghimi A, Aazami NS (2011) The effect of scopolamine on avoidance memory and hippocampal neurons in male Wistar rats. Basic Clin Neurosci 3:9–15Google Scholar
- Yu WH, Dong XQ, Hu YY, Huang M, Zhang ZY (2012) Ginkgolide B reduces neuronal cell apoptosis in the traumatic rat brain: possible involvement of Toll-like Receptor 4 and nuclear factor kappa B pathway. Phytotherapy Research in pressGoogle Scholar